Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Environmental Research|August 17, 2021
Elucidating the microbial ecological mechanisms on the electro-fermentation of caproate production from acetate via ethanol-driven chain elongationShuanglan Cheng, Zhihong Liu, Cristiano Varrone, et al.
RSC Advances|August 23, 2024
Engineering Escherichia coli with a symbiotic plasmid for the production of phenylpyruvic acidTianzhen Xiong, Qiuyue Gao, Jiting Zhang, et al.
Nature Communications|October 31, 2024
Resolving optimal ionomer interaction in fuel cell electrodes via operando X-ray absorption spectroscopyMengnan Wang, Jiaguang Zhang, Silvia Favero, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trialLanlan Pan, Yitong Tian, Kangxin Wang, et al.
Environmental Research|May 7, 2026
A novel selection strategy of microbial consortia for improving crack self-healing in mass concrete via thermal pretreatment: Preliminary testsShanshan Xie, Yiyang Liu, Qianxu Li, et al.
Nature Communications|July 28, 2017
Thermally stable single atom Pt/m-Al2O3 for selective hydrogenation and CO oxidationZailei Zhang, Yihan Zhu, Hiroyuki Asakura, et al.
Chemical Science|August 1, 2018
Efficient cleavage of aryl ether C-O linkages by Rh-Ni and Ru-Ni nanoscale catalysts operating in waterSafak Bulut, Sviatlana Siankevich, Antoine P van Muyden, et al.
Cancer Science|November 4, 2024
Camrelizumab combined with gemcitabine and apatinib in treating advanced PD-L1-positive biliary tract cancersYitong Tian, Changxian Li, Ke Jin, et al.
Frontiers in Immunology|November 29, 2023
Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: a protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study)Yizhang Chen, Jiaguang Zhang, Gaohua Han, et al.
NPJ Precision Oncology|April 8, 2025
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatmentShiyun Cui, Hejian Zheng, Yiyang Xu, et al.
Pageof 3